100 μg | 200 μg | |
---|---|---|
No. patients enrolled | 13 | 12 |
Sex | ||
Male | 13 | 11 |
Female | 0 | 1 |
Age | ||
Median | 69 | 64.5 |
Range | 49-72 | 53-79 |
Prior therapy | ||
Surgery | 6 | 5 |
Radiotherapy | 11 | 7 |
Chemotherapy | 13 | 12 |
Pre-existing antibody to NY-ESO-1 antigen | 3 | 7 |
No. vaccinations | ||
Median | 8 | 9.5 |
Range | 2-27 | 3-21 |